In Vivo Anti Neoplastic Activity Of Ascorbic Acid F...[in Vivo. 1988 Mar-apr] - Pubmed Result

A service of the U.S. National Library of Medicine and the National Institutes of Health

All Databases

Search

PubMed

Nucleotide

PubMed

Limits Clear

Preview/Index

Protein

Genome

Structure

OMIM

My NCBI [Sign In] [Register] PMC

Journals

Books

History

Clipboard

Advanced Search

Go

for Details

Note: Performing your original search, In Vivo Antineoplastic Activity of Ascorbic Acid for Human Mammary Tumor, in PubMed will retrieve 2 records.

Display All: 1

AbstractPlus

Show

20

Sort By

Send to

Review: 0 Links

1: In Vivo. 1988 Mar-Apr;2(2):147-50.

In vivo antineoplastic activity of ascorbic acid for human mammary tumor.

Related Articles Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts. [Am J ClinNutr. 1991]

Tsao CS, Dunham WB, Leung PY. Linus Pauling Institute of Science and Medicine, Palo Alto, CA 94306.

The effect of ascorbic acid on the growth of human mammary tumor xenografts was investigated using the 6-day subrenal capsule assay method. The results showed that ascorbic acid (1 or 5 g/liter) administered in the drinking water significantly inhibited the growth of tumor fragments implanted beneath the renal capsule of immunocompetent mice. The results agree with other work carried out in animal experiments with animal tumors. Administration of ascorbic acid in the mouse diet did not affect the growth of the human mammary tumor fragments within the 6-day experimental period. Tumor growth was inhibited when mice were fed a diet containing ascorbic acid (50g/kg diet) together with cupric sulfate (18 or 90 mg/liter) in the drinking water. The results support the hypothesis that certain oxidation and degradation products of ascorbic acid are active antineoplastic agents for the human mammary carcinoma studied. PMID: 2979831 [PubMed - indexed for MEDLINE]

Ascorbic acid with cupric ions as a chemotherapy for human lung tumor xenografts implanted beneath the renal capsule of immunocompetent[Imice. nVivo. 1992] Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assay. [Cancer. 1981] Review Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, [I nt JT Sodium oxicol. 2005] Review Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum [I ntannuum JT oxicol.fruit 2007] » See Reviews...

|

» See All...

Patient Drug Information Ascorbic Acid (Cecon® Drops, Cenolate® , Cevi-Bid® , ...) Ascorbic acid is used to prevent and treat scurvy, a disease caused by a lack of vitamin C in the body. Source: AHFS Consumer Medication Information

Recent Activity Turn Off

Clear

In vivo antineoplastic activity of ascorbic acid for human mammary tumor. Antitumor activity of ascorbic acid in combination with antitumor agents against Lewis lun... Effect of ascorbic acid on the intragastric environment in patients at increased risk of d... Ultrastructure and cell surface studies of cancer cells following vitamin C administration... Potential protective effect of vitamin C on carcinogenesis caused by nitrosamine in drinki...

Display

AbstractPlus

Show

20

Sort By

Send to

Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer